Ondansetrone Teva (Ondansetron)

• Ondansetron acts on the serotonergic pathway to control nausea and vomiting in several clinical settings.
• Chemotherapy‑induced nausea and vomiting: reduces the frequency and severity of emesis in patients receiving cytotoxic drugs.
• Radiation‑induced nausea and vomiting: lessens acute nausea during cancer radiotherapy.
• Postoperative nausea and vomiting: prevents emesis after surgical procedures.

• Ondansetron selectively blocks the 5‑HT3 receptors located on vagal nerve terminals and in the chemoreceptor trigger zone of the brain. By inhibiting serotonin binding at these sites, it interrupts the neural signaling cascade that initiates the vomiting reflex, thereby providing antiemetic protection during chemotherapy, radiation, and surgery.

Common Side Effects

• Headache: mild to moderate intensity.
• Constipation: reduced bowel movements.
• Dizziness: transient light‑headedness.
• Fatigue: feeling of tiredness.
• Diarrhoea: loose stools.
• Abdominal pain: mild cramping.

Serious or Rare Side Effects

• QT interval prolongation: may lead to cardiac arrhythmia.
• Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty.
• Serotonin syndrome: agitation, hyperthermia, neuromuscular abnormalities.
• Cardiac arrhythmia: irregular heartbeat.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

• Before using Ondansetrone Teva, consider the following safety points.
• Assess cardiac history: monitor QT interval in patients with known heart disease.
• Review concomitant medications: avoid or adjust drugs that also prolong QT.
• Use with caution in hepatic impairment: dose may need adjustment.
• Use with caution in renal impairment: monitor renal function.
• Pregnancy and lactation: weigh potential benefits against risks; consult a specialist.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Ondansetron can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

• Apomorphine: may cause severe hypotension.
• Other QT‑prolonging agents (e.g., quinidine, amiodarone): increase risk of cardiac arrhythmia.
• Carbamazepine: induces metabolism, reducing ondansetron efficacy.

Moderate Interactions (Monitor Closely)

• Aprepitant: may enhance antiemetic effect; monitor for additive QT prolongation.
• Warfarin: possible alteration of anticoagulant effect; check INR.
• Oral contraceptives: may reduce hormonal efficacy; advise alternative contraception if needed.